Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Individuals diagnosed with cancer who are continuing treatment at home, and who are between 40 and 95 years of age at the time of obtaining informed consent. 2. Individuals who voluntarily request to receive aromatherapy treatment. 3. Individuals who are judged by their attending physicians to be eligible for participation in this study. 4. Individuals who are determined by their attending physicians not to require inpatient treatment for the time being. 5. Individuals who have received a sufficient explanation of this study, have understood its content, and have provided written informed consent to participate.
Exclusion criteria
Exclusion criteria: 1. Individuals with allergies to nuts, particularly those with almond allergy. 2. Individuals who are judged by their attending physician to be likely to experience an adverse impact on their medical treatment as a result of participation in this study. 3. Individuals who have been diagnosed by their attending physician as having terminal cancer or being in an end of life condition. 4. Individuals who show a positive reaction to the essential oils used in this study in a patch test conducted prior to aromatherapy treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Salivary stress related hormones before and after aromatherapy treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain assessed by the Visual Analogue Scale (VAS) and mood assessed by the Two Dimensional Mood Scale (TDMS) before and after aromatherapy treatment | — |
Countries
Japan
Contacts
Tori Aroma Therapy Laboratory Director